Aktie A3CPS3 ORION BIOTECH OPPORTUNITIES CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Orion Biotech Opportunities Corp. OTC Markets

Aktien

A3CPS3

KYG6780C1252

ORIAU

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Orion Biotech Opportunities Corp.(OTCPK:ORIA) dropped from NASDAQ Composite Index
Orion Biotech Opportunities : will redeem its Public Shares and will not consummate an initial business combination - Form 8-K
ORION BIOTECH OPPORTUNITIES CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Orion Biotech Opportunities Corp. Auditor Raises 'Going Concern' Doubt
Orion Biotech Opportunities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Orion Biotech Opportunities Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Orion Biotech Opportunities Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Orion Biotech Opportunities Corp. Reports Earnings Results for the Eleven Months Ended December 31, 2021
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
ORION BIOTECH OPPORTUNITIES CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Certain Class B Ordinary Shares of Orion Biotech Opportunities Corp. are subject to a Lock-Up Agreement Ending on 9-NOV-2021.
ORION BIOTECH OPPORTUNITIES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Orion Biotech Opportunities Corp. has completed an IPO in the amount of $200 million.
Orion Biotech Opportunities Corp. has filed an IPO in the amount of $200 million.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CWEV Aktie
  4. A3CPS3 Aktie
  5. Nachrichten Orion Biotech Opportunities Corp.
  6. Andere Sprachen